The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1472
Liletta - A Third Levonorgestrel-Releasing IUD
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Liletta - A Third Levonorgestrel-Releasing IUD
The FDA has approved Liletta, an intrauterine device (IUD) that releases the synthetic progestin levonorgestrel, for prevention of pregnancy for up to 3 years. The fourth IUD to be approved in the US, and the third that releases levonorgestrel,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Liletta - A Third Levonorgestrel-Releasing IUD
Article code: 1472b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.